small cap stocks « AGORACOM Small-cap Investor Relations Blog

Posts Tagged ‘small cap stocks’

ImagineAR $IP.ca $IPNFF Announces Partnership with BookYourStadium.com in Spain $DBO.ca $YDX.ca $SEV.ca $NTAR.ca

Posted by AGORACOM-JC at 7:49 AM on Monday, January 25th, 2021

http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg

Announced a partnership agreement with BOOK YOUR STADIUM ( www.bookyourstadium.com ) to deliver ‘one-of-a-kind’ AR experiences from historical soccer clubs in LaLiga ( Spain ) to fans around the world.
The clubs which BOOK YOUR STADIUM is currently offering in the platform are REAL MADRIDCF , REAL SOCIEDAD CF , REAL VALLADOLID CF, VALENCIA CF, ATHLETIC CLUB , CA OSASUNA , REAL BETIS BALOMPIÉ, and RC CELTA .
Throughout 2021, several national and international clubs are expected to join the platform.

VANCOUVER, BC and ERIE, Pa. , Jan. 25, 2020 – ImagineAR (IP:CSE) (IPNFF:OTCQB) an Augmented Reality company that enables sports teams, entertainers, brands and businesses to instantly create immersive global mobile phone AR campaigns, is excited to announce a partnership agreement with BOOK YOUR STADIUM ( www.bookyourstadium.com ) to deliver ‘one-of-a-kind’ AR experiences from historical soccer clubs in LaLiga ( Spain ) to fans around the world. The clubs which BOOK YOUR STADIUM is currently offering in the platform are REAL MADRIDCF , REAL SOCIEDAD CF , REAL VALLADOLID CF, VALENCIA CF, ATHLETIC CLUB , CA OSASUNA , REAL BETIS BALOMPIÉ, and RC CELTA . Throughout 2021, several national and international clubs are expected to join the platform.

Joaquín Martínez, CEO of BOOK YOUR STADIUM , states: ” We have developed a revolutionary online e-commerce fan engagement site and incorporated ‘best of breed’ innovative digital products. ImagineAR is a leader for sports fan AR engagement and we are going to partner on unique fan AR immersive experiences featuring top LaLiga soccer club players. Additionally, we are now an authorized ImagineAR partner to market their SDK platform to LaLiga clubs for integration into their existing mobile apps which are used by tens of millions of fans around the world.”

BOOK YOUR STADIUM ( www.bookyourstadium.com ), currently available in Spanish, is expected to be available in English in February 2021 and expand globally. Initially, soccer fans can choose from over 200 experiences, adapted to the current health restrictions, to select from historical clubs in LaLiga. Some examples of experiences available include: access to virtual match experiences with exclusive content and games, e-sports matches with football players, Immersive AR experiences, virtual autographs, original match day events, or enjoy club lunch at home. In addition, there is the option of the SPORTBOX® , a themed gift box full of surprises with selected experiences from some clubs.

Read More: https://agoracom.com/ir/Imaginear/forums/discussion/topics/753838-imaginear-announces-partnership-with-bookyourstadium-com-in-spain/messages/2300007#message

Tags: Apple, AR, augmented reality, Camerai, CSE, D-BOX Technologies Inc., investment, small cap, small cap stocks, stocks, Tipit
Posted in Featured, Imagine AR | Comments Off on ImagineAR $IP.ca $IPNFF Announces Partnership with BookYourStadium.com in Spain $DBO.ca $YDX.ca $SEV.ca $NTAR.ca

Empower Clinics $CBDT.ca $EPWCF Doubling KAI Medical Laboratory Size In Anticipation Of Test Volumes By End Of Q1. Files MDEL Application With Health Canada To Import and Sell KAI Saliva PCR Test In Canada $WELL.ca $DOC.ca $DOCRF $VMD.ca

Posted by AGORACOM-JC at 7:58 AM on Thursday, January 21st, 2021

Announced significant expansion of our KAI Medical Laboratory in Dallas, Texas in anticipation of projected growth in COVID-19 testing requirements in the U.S., Canada and international markets.
In addition, Empower has filed a Medical Device Establishment Licence with Health Canada for the purposes of importing, distributing and selling our KAI Medical COVID-19 Saliva Test, which has experienced immediate success since it’s launch on December 15, 2020 in the United States and reported on January 7, 2021.

VANCOUVER, BC / January 21, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(OTCQB:EPWCF)(Frankfurt:8EC) (“Empower” or the “Company“) an integrated healthcare company serving patients through clinics, a telemedicine platform, and a leading medical diagnostics laboratory processing thousands of COVID-19 specimens and developing novel COVID-19 testing protocols for CE, FDA EUA and Health Canada approval, is pleased to announce significant expansion of our KAI Medical Laboratory in Dallas, Texas in anticipation of projected growth in COVID-19 testing requirements in the U.S., Canada and international markets.

In addition, Empower has filed a Medical Device Establishment Licence (“MDEL”) with Health Canada for the purposes of importing, distributing and selling our KAI Medical COVID-19 Saliva Test (“KAI Saliva”), which has experienced immediate success since it’s launch on December 15, 2020 in the United States and reported on January 7, 2021.

KAI MEDICAL LABORATORY EXPANDING TO AT LEAST DOUBLE CURRENT SIZE IN ANTICIPATION OF ANTICIPATED GROWTH IN VOLUME

KAI Medical Laboratory, a state-of-the-art diagnostics laboratory in Dallas, was acquired by Empower Clinics on October 6, 2020 to further advance the Company’s COVID-19 national testing programs for enterprise clients, including movie and television studios, businesses and the travel industry. KAI experienced significant growth in its first quarter under Empower, with Q4 COVID-19 test kit volumes exceeding 6,000 units, far surpassing the 1,300 total units prior to acquisition.

Current run rate projections now indicate as follows:

January 2021 is expected to exceed 8,000 tests, surpassing all of Q4 2020
February 2021 could see daily rates hit 1,000 tests per day
March 2021 could see daily rates hit 2,000 tests per day

These run rates DO NOT include the recent 25,000 unit order for KAI Saliva test kits, nor do they include any test kits from the launch of KAItests.com

Empower Clinics CEO, Steven McAuley stated “Our investment in R&D is really starting to pay off for KAI Medical, starting with a new state-of-art laboratory information system to automate processes for the anticipated growth in volume. Next, we have hired three new scientists, increased administrative staff and are activating a call center to provide world-class customer support. Further, the investment in new test protocols such as the Kai Saliva test kit, combined with our Health Canada medical device licence, positions us to be a leader in the reactivation of travel for Canadians.”

Read More: https://agoracom.com/ir/EmpowerClinics/forums/discussion/topics/753555-empower-clinics-doubling-kai-medical-laboratory-size-in-anticipation-of-test-volumes-by-end-of-q1-files-mdel-application-with-health-canada-to/messages/2299214#message

Tags: covid19, Covid19 testing, CSE, Diagnos Inc, investments, Kai Medical Laboratory, small cap stocks, tsx
Posted in Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca $EPWCF Doubling KAI Medical Laboratory Size In Anticipation Of Test Volumes By End Of Q1. Files MDEL Application With Health Canada To Import and Sell KAI Saliva PCR Test In Canada $WELL.ca $DOC.ca $DOCRF $VMD.ca

Victory Square Technologies $VST.ca $VSQTF Portfolio Company, Immersive Tech, Announces the Creation of World’s First #COVID-safe Location-Based Entertainment (LBE) Virtual Reality #VR Division “UNCONTAINED” $DBO.ca $YDX.ca $SEV.ca $NTAR.ca

Posted by AGORACOM-JC at 8:42 AM on Wednesday, January 20th, 2021

Company launches first-ever COVID-safe location-based (LBE) Virtual Reality attractions division “UNCONTAINED” to disrupt the marketplace and fulfill demand from its Family Entertainment Center (FEC) clients.
Immersive Tech is planning for a public listing in the first half of 2021.
Leading immersive experience company builds upon current and past relationships with major companies.
Announcement brings creation of the world’s first-ever free-roam interactive VR franchise attraction available for rapid sale to the global attraction and entertainment marketplace.

VANCOUVER, British Columbia, Jan. 20, 2021 — Victory Square Technologies Inc. (“VST”) (CSE:VST) (OTC:VSQTF) (FWB:6F6) , a company that provides investors access to a diverse portfolio of companies in key sectors including: digital health, gaming, blockchain, AR/VR, cybersecurity, and cloud computing, is pleased to announce that its portfolio company Immersive Tech (“Company”) has launched a premiere new Location-Based Entertainment (LBE) VR attractions division named UNCONTAINED to capitalize on the growing demand for COVID-safe attractions. UNCONTAINED will be the world’s first free-roam interactive VR franchise attraction, built for a COVID world within shipping containers. The experience will allow for up to six players to roam freely within the container while interacting inside a digital environment as a team while making decisions that help guide and define the story.

Immersive Tech designs, engineers and builds custom technology-driven experiences, whether they facilitate brand integration or are aiming to create the best real life adventure possible. The Company recently announced the creation of three unique entertainment escape rooms custom designed and built for Apex Entertainment’s new location in Virginia Beach VA, USA. The three custom room themes include an underwater submarine adventure, a post-war bunker experience, and an AI-controlled warship gone rogue featuring a race against time and a family-friendly focus.

“UNCONTAINED” leverages the manner of design experience that Immersive Tech has gained and honed over the past four years in creating and launching highly successful interactive escape rooms for Family Entertainment Centers. This is complemented by a fundamental understanding of shipping containers as highlighted in their recent 3-room escape experience for Leaps by Bayer, a Bayer Pharmaceutical company, in 2020.

Read More: https://agoracom.com/ir/VictorySquareTechnologies/forums/discussion/topics/753450-victory-square-technologies-portfolio-company-immersive-tech-announces-the-creation-of-world-s-first-covid-safe-location-based-entertainment/messages/2299018#message

Tags: small cap, small cap stocks, stocks, telehealth, telemedicine, tsx
Posted in Victory Square Technologies Inc. | Comments Off on Victory Square Technologies $VST.ca $VSQTF Portfolio Company, Immersive Tech, Announces the Creation of World’s First #COVID-safe Location-Based Entertainment (LBE) Virtual Reality #VR Division “UNCONTAINED” $DBO.ca $YDX.ca $SEV.ca $NTAR.ca

Victory Square $VST.ca $VSQTF Technologies Signs Binding Letter of Intent to Acquire IV Hydreight, An On-Demand & On-Site Mobile #Health, #Pharmaceutical & #Wellness Service Provider Across the United States $WELL.ca $DOC.ca $DOCRF $VMD.ca

Posted by AGORACOM-JC at 9:19 AM on Tuesday, January 19th, 2021

Hydreight provides a completely compliant turnkey business model for health professionals to offer fully licensed medical, health & wellness services through an on-demand and on-site platform.
In addition to providing telehealth services, Hydreight also provides a diverse suite of health & wellness protocols that include IV drip, Botox, COVID-19 testing, and other medical and medispa treatments.
Hydreight is a USA certified e-script and telemedicine provider, allowing Hydreight to offer a wide array of health and medical services in all 50 states.
Hydreight provides full pharmaceutical offerings across the United States (Hydreight has full 503B Pharmaceutical supply capabilities ).
Hydreight has established key relationships and supply network chains with major vendors including: Medline, Mckesson, Allergan (Botox), Galderma and numerous pharmacies.

VANCOUVER, British Columbia, Jan. 19, 2021 — Victory Square Technologies Inc. (” Victory Square ” or the “ Company ”) (CSE:VST) (OTC:VSQTF) (FWB:6F6), a company that provides investors access to a diverse portfolio of companies in key sectors including: digital health, gaming, blockchain, AR/VR, cybersecurity, and cloud computing, is pleased to announce that it has signed a binding letter of intent (the “ LOI ”) dated January 13, 2021 in respect of the acquisition (the “ Acquisition ”) of all of the shares of IV Hydreight Inc. (“ Hydreight ”), a mobile health and wellness service provider operating in the United States.

Founded in 2018, Hydreight provides a unique, custom built, proprietary telemedicine service that allows users to book confidential health & wellness and/or medical services at their home, hotel, office or wherever they may need discreet assistance. The business model of Hydreight leverages decentralized healthcare to bring quality telehealth, medical, health and wellness services to the masses in an efficient, scalable and cost effective way.

Read More: https://agoracom.com/ir/VictorySquareTechnologies/forums/discussion/topics/753355-victory-square-technologies-signs-binding-letter-of-intent-to-acquire-iv-hydreight-an-on-demand-on-site-mobile-health-pharmaceutical-wellness/messages/2298763#message

Tags: small cap, small cap stocks, stocks, telehealth, telemedicine, tsx, tsx-v
Posted in All Recent Posts, Victory Square Technologies Inc. | Comments Off on Victory Square $VST.ca $VSQTF Technologies Signs Binding Letter of Intent to Acquire IV Hydreight, An On-Demand & On-Site Mobile #Health, #Pharmaceutical & #Wellness Service Provider Across the United States $WELL.ca $DOC.ca $DOCRF $VMD.ca

POET Technologies $PTK.ca $POETF Opens Product Design and Development Center in Shenzhen, China

Posted by AGORACOM-JC at 9:09 AM on Tuesday, January 19th, 2021

Announces Appointment of Dr. Jinyu Mo as Senior Vice President, Asia

Opened a product design and development center in Shenzhen, China, which will be focused on the optical engine, reference designs for customer applications and new product activities.
POET also announced the appointment of Dr. Jinyu Mo as its Senior Vice President of Asia, with responsibility for managing the Company’s activities in China and Singapore. Dr. Mo is a highly experienced technical and business veteran of the photonics and optoelectronics industries.

TORONTO, Jan. 19, 2021 — POET Technologies Inc. (“ POET ” or the “ Company ”) (TSX Venture: PTK; OTCQX: POETF), the designer and developer of the POET Optical Interposer™ and Photonic Integrated Circuits (PICs) for the data center and tele-communication markets, announced today that it has opened a product design and development center in Shenzhen, China, which will be focused on the optical engine, reference designs for customer applications and new product activities.

POET also announced the appointment of Dr. Jinyu Mo as its Senior Vice President of Asia, with responsibility for managing the Company’s activities in China and Singapore. Dr. Mo is a highly experienced technical and business veteran of the photonics and optoelectronics industries. She has over 22 years of experience spanning several companies, including MACOM Technology Solutions, Bookham/Oclaro, Huawei, I2R in Singapore and Nexvave Photonics Technology Co., which she founded and served as Chief Technology Officer. Dr. Mo was most recently with MACOM as the Senior Director and Chief Scientist of the Lightwave business unit in Asia and site leader in Shenzhen. Dr. Mo received her PhD degree in Optical Communications from Nanyang Technological University (NTU) Singapore. She is a Senior member of IEEE and has been a member of IEEE’s Technical Committees for several international conferences.

POET Optoelectronics Shenzhen Co. Ltd., a wholly foreign-owned enterprise (WFOE) and wholly-owned subsidiary of POET, will augment the Company’s existing design, development and engineering operations in Allentown, Pennsylvania and Singapore. The Shenzhen operation will also support the activities of Super Photonics Xiamen Co. Ltd., the Company’s joint venture with Sanan IC, a subsidiary of Sanan Optoelectronics Co., Ltd. (Shanghai Stock Exchange, SSE: 600703).

Read more: https://agoracom.com/ir/POETTechnologies/forums/discussion/topics/753362-poet-technologies-opens-product-design-and-development-center-in-shenzhen-china/messages/2298780#message

Tags: AI, Cloud Computing, lightbar, photonics, small cap, small cap stocks
Posted in POET Technologies | Comments Off on POET Technologies $PTK.ca $POETF Opens Product Design and Development Center in Shenzhen, China

Former #LifeLabs COO Joins Novamind $NM.ca Leadership Team $RVV.ca $MMED $PSYC.ca

Posted by AGORACOM-JC at 8:05 AM on Tuesday, January 19th, 2021

Pierre Bou-Mansour is former COO of LifeLabs, one of Canada’s largest medical service companies

Announced the expansion of its leadership team with the appointment of Pierre Bou-Mansour, P.Eng., to the role of Chief Operating Officer.
Effective immediately, Mr. Bou-Mansour will assume responsibility for ensuring operational excellence as Novamind develops its network of clinics, retreats, and research sites in 2021 and beyond.
Most recently, he served as the Chief Laboratory Operations Officer of Public Health Ontario, serving Canada’s largest province with over 14 million residents.
In this role, Bou-Mansour successfully led the expansion of Public Health Ontario’s testing capacity for the COVID-19 response.

TORONTO, ON / January 19, 2021 / Novamind Inc., (CSE:NM) (“Novamind” or the “Company”) a mental health company specialized in psychedelic medicine, announces the expansion of its leadership team with the appointment of Pierre Bou-Mansour, P.Eng., to the role of Chief Operating Officer. Effective immediately, Mr. Bou-Mansour will assume responsibility for ensuring operational excellence as Novamind develops its network of clinics, retreats, and research sites in 2021 and beyond.

An accomplished senior executive and leader, Pierre brings a wealth of experience managing large and complex healthcare organizations. Most recently, he served as the Chief Laboratory Operations Officer of Public Health Ontario, serving Canada’s largest province with over 14 million residents. In this role, Bou-Mansour successfully led the expansion of Public Health Ontario’s testing capacity for the COVID-19 response.

Pierre Bou-Mansour said, “Novamind’s Cedar Psychiatry clinics and Cedar Clinical Research sites are both well-positioned to scale as regulated access to psychedelic medicine continues to expand rapidly in jurisdictions around the world. I look forward to working with the leadership team to ensure strategic expansion of our operating model for clinical care and clinical research in psychedelic medicine.”

Pierre has a proven track record for growing and transforming healthcare companies. He spent eight years at LifeLabs, serving as the COO from 2017 to 2019, and successfully led the integration of two acquired competitors. During this period, LifeLabs grew into one of the largest medical service companies in Canada, with over 5,700 employees, 370 patient access sites, and over US $977 million in annualized revenue (dnb.com).

Yaon Conforti, Chief Executive Officer and Director of Novamind added, “Pierre brings a distinguished operational track record in healthcare to drive the expansion of Novamind’s network of mental health clinics and clinical research sites. His role is critical as we execute against our pipeline of growth opportunities.”

Tags: CSE, Psychedelic, psychedelic medicine, small cap stocks, stocks, tsx, tsx-v, wellness clinics
Posted in Novamind Inc. | Comments Off on Former #LifeLabs COO Joins Novamind $NM.ca Leadership Team $RVV.ca $MMED $PSYC.ca

Empower Clinics $CBDT.ca $EPWCF Announces First Ever AGORACOM Video Q&A with Shareholders Submitting Questions for Direct Response by CEO Steven McAuley $WELL.ca $DOC.ca $DOCRF $VMD.ca

Posted by AGORACOM-JC at 7:47 AM on Tuesday, January 19th, 2021

Shareholders are able to submit questions by either:

Posting directly to the Empower Verified Forum on AGORACOM at https://agoracom.com/ir/EmpowerClinics/forums/discussion and checking the “?” box
Posting on Twitter to both @EmpowerClinics and @Agoracom with the any of the following hashtags #empowerclinics_QA, #CBDTQA, #CBDT_QA

Questions must be posted by no later than Wednesday, January 20th, 5PM EST.

With Empower Clinics Entering Growth Phase On Multiple Business Fronts, Chairman & CEO Steven McAuley Provides Shareholders With An Opportunity To Fully Participate In Company’s First AGORACOM Video Q&A

VANCOUVER, BC / January 19, 2021 / EMPOWER CLINICS INC. (CBDT:CSE) (8EC:Frankfurt) (EPWCF:OTCQB) (“Empower” or the “Company“) an integrated healthcare company serving patients through medical clinics in USA and Canada, a telemedicine platform, and a leading medical diagnostics laboratory processing thousands of COVID-19 specimens and developing novel COVID-19 testing protocols for CE, FDA EUA and Health Canada approval, is pleased to announce its first ever AGORACOM Video Q&A, which provides investors with the opportunity to submit questions for response by Chairman & CEO Steven McAuley.

Empower Clinics CEO Steven McAuley stated “With so much tremendous progress taking place for our company, as we head into what I expect to be our breakthrough and greatest year ever in 2021, I want to make sure shareholders have an opportunity to ask questions, receive answers directly from me and begin the process of regular engagement through our Verified Forum on AGORACOM. I am looking forward to engaging with shareholders and followers on the interview.”

VIDEO Q&A DETAILS

Shareholders are able to submit questions by either:

Posting directly to the Empower Verified Forum on AGORACOM at https://agoracom.com/ir/EmpowerClinics/forums/discussion and checking the “?” box
Posting on Twitter to both @EmpowerClinics and @Agoracom with the any of the following hashtags #empowerclinics_QA, #CBDTQA, #CBDT_QA

Questions must be posted by no later than Wednesday, January 20th, 5PM EST.

Read more: https://agoracom.com/ir/EmpowerClinics/forums/discussion/topics/753351-empower-clinics-announces-first-ever-agoracom-video-q-a-with-shareholders-submitting-questions-for-direct-response-by-ceo-steven-mcauley/messages/2298759#message

Tags: covid19, Covid19 testing, CSE, Diagnos Inc, investments, Kai Medical Laboratory, small cap stocks
Posted in Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca $EPWCF Announces First Ever AGORACOM Video Q&A with Shareholders Submitting Questions for Direct Response by CEO Steven McAuley $WELL.ca $DOC.ca $DOCRF $VMD.ca

Tartisan Nickel $TN.ca: Poised For A Breakout Year! Resource Expansion & Exploration Ramp Up IS Coming IN 2021 $RNX.ca $TSLA $NOB.ca $SHL.ca $CNC.ca $FPC.ca $NICO.ca

Posted by AGORACOM at 10:33 AM on Monday, January 18th, 2021

Morgan Stanley on Nickel Forecast:

6.4% demand growth in 2021
- outpacing supply as Indo NPI growth offset by China’s decline
Market moving from 85kt surplus in 2020 to -18kt in ’21
- Supporting average price of $7.29/lb, with risk skewed to bull case $8.75/lb

Tartisan Investment Highlights:

Kenbridge Nickel Deposit is a Class 1 Nickel project which can safely be put into production quickly at low capital cost
Updated Mineral Resource Estimate: 7.47 Ktonnes 0.6% Ni, 0.32% Cu open pit and underground
Measured and Indicated resources 985 Ktonnes Inferred at 1% Ni, 0.62% or 117 million pounds of Nickel and 66 million pounds of Copper
Potential to double the underground resource at Kenbridge through anticipated drill program
Kenbridge North – Untested Potential to Discover additional Class 1 Deposits

Tartisan Strategic Investment Holdings $9+ Million

Eloro Resources, Class One Nickel and Technologies , Peruvian Metals Corp. provide Tartisan shareholders an opportunity to participate in other high-quality projects

Kenbridge Ni Project (Kenora, Ontario)

Property is accessible via gravel roads from paved Highway 71
Underground development of the deposit extends from surface to a depth of 623 metres in a 3 compartment shaft, with 244 metres of drifts and 168 metres of crosscuts at the 110 and 150 metre levels
The minimum drill spacing is at 15.2metres on all levels.
The deepest hole extends to 838.4 metre depth and intersected mineralization grading 4.25% nickel and 1.38% copper over 10.7 metres, indicating that the deposit remains open at depth.
Historical surface drilling was completed at 30.5metre spacing
Preliminary Economic Assessment completed and updated returned robust project economics and operating costs including a NPV of C$253M and cash costs of US$3.47/lb of nickel net of copper credits

Look for Tartisan Corporate updates in 2021 at Tartisan.com

Tags: #Battery, #Demand, #ELO, #ElonMusk, #TN, CSE, EloroResources, Kenbridge, nickel, nickel demand, PEA, small cap stocks
Posted in All Recent Posts, Tartisan Resources | Comments Off on Tartisan Nickel $TN.ca: Poised For A Breakout Year! Resource Expansion & Exploration Ramp Up IS Coming IN 2021 $RNX.ca $TSLA $NOB.ca $SHL.ca $CNC.ca $FPC.ca $NICO.ca

Draganfly $DFLY.ca $DFLYF CEO Cameron Chell to be Featured on “Making Money with Charles Payne” on Fox Business $FLT.ca $UAVS $ALPP

Posted by AGORACOM-JC at 9:25 AM on Monday, January 18th, 2021

Announced today that the CEO of the Company, Cameron Chell, will be featured on “Making Money with Charles Payne” on Fox Business.
Segment on Fox Business will focus on Draganfly’s recent announcements in relation to Draganfly’s Varigard spraying program which provides 24-hour sequestration and kill efficacy against pathogens including COVID-19 in a single application.

Los Angeles, CA, Jan. 18, 2021 — Draganfly Inc. (CSE: DFLY) (OTCQB: DFLYF) (FSE: 3U8) (“ Draganfly ” or the “ Company ”), an award-winning, industry-leading manufacturer and systems developer‎, announced today that the CEO of the Company, Cameron Chell, will be featured on “Making Money with Charles Payne” on Fox Business.

The segment on Fox Business will focus on Draganfly’s recent announcements in relation to Draganfly’s Varigard spraying program which provides 24-hour sequestration and kill efficacy against pathogens including COVID-19 in a single application.

“I am super excited to share our story with Charles Payne on Fox Business,” said Cameron Chell, CEO Draganfly. “The surface disinfecting market size is surging and expected to reach $1.5 billion by 2027, due in part to the requirement to disinfect large areas like stadiums. Varigard ™ has already established a technical leadership position and we look forward to providing the most advanced drones and services to their customers.”

Cameron Chell’s segment on Fox Business with Charles Payne will air at 2PM ET on Monday, January 18.

Read More: https://agoracom.com/ir/Draganfly/forums/discussion/topics/753259-draganfly-ceo-cameron-chell-to-be-featured-on-making-money-with-charles-payne-on-fox-business/messages/2298572#message

Tags: AGEAGLE AERIAL SYSTEMS, AI, ALPINE 4 TECHNOLOGIES, CSE, DRONE DELIVERY CANADA, Drones, investments, small cap, small cap stocks
Posted in Draganfly Inc. | Comments Off on Draganfly $DFLY.ca $DFLYF CEO Cameron Chell to be Featured on “Making Money with Charles Payne” on Fox Business $FLT.ca $UAVS $ALPP

Posts Tagged ‘small cap stocks’

Announces Appointment of Dr. Jinyu Mo as Senior Vice President, Asia

Categories